Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.

Market Cap	$148.83M	P/E Ratio	N/A
52W High	$2.61	52W Low	$0.74
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	65.8%	52W Position	4.7%
Overall Score	33	Value Score	20
Quality Score	52	Technical Score	27

EPS Current Est	$-0.04	EPS Next Est	$0.14
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HRTX	$0.83	+4.52%	1.05M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HRTX	$0.83	+4.5%	1.05M
3
4
5
6

HRTX

HRTX

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Heron Therapeutics Inc. Data in Excel

Get Heron Therapeutics Inc. Data in Excel